|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02329 GLORY HEALTH
Nominal 
0.141 0.000 (0.000%) | 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Turnover | 987,459 | -32.220% | 1,456,867 | 2,946,268 | 6,574,553 | 3,322,365 |
| Cost of Sales | (555,182) | -56.515% | (1,276,717) | (3,122,585) | (5,526,682) | (2,450,965) |
| Gross Profit | 432,277 | 139.954% | 180,150 | (176,317) | 1,047,871 | 871,400 |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (269,961) | -- | -- | -- | 94,620 | 238,363 | |
| Change in FV & Impairment on Others | -- | -- | (16,762) | (69,254) | (2,694) | (5,178) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (5,188) | -53.815% | (11,233) | (1,280) | (9,346) | (9,335) | |
| Profit / (Loss) before Taxation | (125,163) | -56.124% | (285,266) | (854,725) | 824,675 | 565,055 | |
| Taxation | 60,719 | 293.029% | 15,449 | 76,901 | (454,112) | (284,032) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 5,786 | 96.602% | 2,943 | 95,340 | (104,017) | (209,717) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (58,659) | -78.020% | (266,874) | (682,484) | 266,546 | 71,306 | |
| 2024/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | 2020/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 38,517 | -72.962% | 142,455 | 331,235 | 92,622 | 220,466 |
| Depreciation & Amortisation | 39,748 | 11.973% | 35,498 | 34,784 | 35,076 | 42,134 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -1.320 | -78.000% | -6.000 | -15.400 | 6.000 | 1.600 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.500 | -- | 2.580 | 2.705 | 2.871 | 2.805 |
| Remarks: | Real time quote last updated: 19/11/2024 11:49 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -58,659,000 |
| %Change | -78.020% |
| EPS / (LPS) | RMB -0.013 |
| NBV Per Share (¥) | RMB 2.500 |